Study record

Effects of graviola oil extract on fattening performance and circadian rhythms of adipokine, cardiac and mitochondrial function markers in lambs

Kotan GC, Bayraktar B · BMC Vet Res · 2026

AnimalEndogenous MOTS-c measuredEvidence tier C

What this study reported

Measured serum MOTS-c as one of several circadian biomarkers in lambs fed a graviola oil extract, and reported that the mid-level supplementation group showed modulated MOTS-c, BMAL1 and BMCP1 profiles with a peak at 19:00. Reported increases in live weight gain in that group relative to unsupplemented lambs.

Limitations

MOTS-c was a secondary ELISA biomarker rather than the study's subject; male lambs only; no mechanistic or tissue-level measurement of MOTS-c.

Study record

Annotated fields for this study
Study modelAnimal study (in vivo)
Substance studiedEndogenous MOTS-c measuredNaturally occurring MOTS-c was measured; nothing was given.
Speciessheep
System studiedMale Anatolian Merino lambs fed graviola oil extract; serum biomarker panel including MOTS-c
PopulationNot reported
DesignControlled animal feeding trial with circadian sampling
Sample size as reported48 male Anatolian Merino lambs
Control groupunsupplemented control group (G0)
Route (data field only)Not reported
Endpoints measuredlive weight and weight gain; feed conversion ratio; serum MOTS-c; serum BMAL1 and BMCP1; serum apelin and cardiac troponin I
Pathways measuredOther
Research areasMetabolic · Mitochondrial biology · Cardiovascular
Evidence tierC — Animal in vivo
Publication typesJournal Article

Appraisal

Each dimension is recorded separately and never combined into a single score. A study can be well controlled and still tell you little about people.

Relevance to MOTS-c
Peripheral
Model applicability
Mammalian
Sample size
Adequate
Controls
Appropriate
Outcome validity
Exploratory
Support for its own conclusion
Weak

Provenance

  • Bibliographic fields retrieved from PubMed E-utilities efetch (title, journal, date, authors, DOI) on 2026-11-11.
  • Annotated from the published abstract.
  • Editorial review: approved (2026-11-11).
  • Classification follows the site methodology; the record describes the study, not what MOTS-c does in people.